Pallas Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Sell
889
-660
-43% -$179K 0.01% 708
2025
Q4
$389K Sell
1,549
-53
-3% -$14.1K 0.01% 604
2025
Q3
$460K Buy
1,602
+19
+1% +$5.09K 0.02% 540
2025
Q2
$416K Sell
1,583
-375
-19% -$91.3K 0.02% 561
2025
Q1
$456K Buy
1,958
+30
+2% +$7.28K 0.02% 495
2024
Q4
$442K Buy
1,928
+5
+0.3% +$1.15K 0.02% 390
2024
Q3
$442K Buy
1,923
+328
+21% +$72.1K 0.02% 384
2024
Q2
$342K Buy
+1,595
New +$324K 0.02% 384
2024
Q1
Sell
-4,980
Closed -$1.13M 444
2023
Q4
$1.13M Buy
+4,980
New +$1.05M 0.06% 197
2022
Q1
Sell
-1,490
Closed -$348K 265
2021
Q4
$348K Sell
1,490
-1,261
-46% -$312K 0.04% 230
2021
Q3
$679K Buy
+2,751
New +$693K 0.07% 191

Other funds holding LH

Pallas Capital Advisors's LH Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Labcorp (LH) stake by 43% in Q1 2026, selling an estimated $179K and leaving 889 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #708.

Pallas Capital Advisors first reported a position in LH in Q3 2021 and has held it in 11 quarters since. The position peaked at $1.13M in Q4 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Pallas Capital Advisors held 889 shares of Labcorp worth $237K as of Q1 2026.
  • Pallas Capital Advisors sold 660 Labcorp shares in Q1 2026, an estimated $179K.
  • Labcorp made up 0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #708 holding.
  • Pallas Capital Advisors first reported a position in Labcorp in Q3 2021 and has held it in 11 quarters since.
  • Pallas Capital Advisors's Labcorp position peaked at $1.13M in Q4 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.